Nyxoah Sa Revenue per Employee (NYXH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nyxoah Sa  (NASDAQ: NYXH)
 

Nyxoah Sa's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 156.29% in the fourth quarter 2025, year on year to cumulative value of $13 million, Nyxoah Sa's revenue per employee grew on a trailing twelve months basis to $ 630,187. The productivity of Nyxoah Sa's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 171 other companies have achieved higher revenue per employee. While Nyxoah Sa's total ranking has deteriorated compared to the previous quarter from 0 to 1640. Nyxoah Sa has 20 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NYXH Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 156.29 % - 82.96 % - 258.85 %
Sales per Employee (TTM) $ 630,187 292,195 292,195 257,767 257,767
NYXH's Total Ranking # 1640 # 0 # # #
Seq. Revenue Change - - - - -

NYXH Company Profile >> Back to NYXH Efficiency Comparisons >> Compare NYXH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 172
Overall Market # 1640

Revenue per Employee Statistics
High Average Low
$ 554,256 $ 554,256 $ 554,256
(Dec 31 2025)  



Financial Statements
Nyxoah Sa's Revenue MRQ $ 11 Millions Visit NYXH's Income Statement
Nyxoah Sa's Revenues TTM $ 13 Millions Visit NYXH's aggregate revenue growth
What are NYXH's Sales? Visit NYXH's Sales by Segment




Other Ratios
Nyxoah Sa's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NYXH's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NYXH's Competitors
Revenue per Employee for NYXH's Suppliers
Revenue per Employee for NYXH's Customers

You may also want to know
NYXH's Sales Growth Rates NYXH's Pe Price to earnings ratio NYXH's Receivables Turnover Ratio NYXH's Stock Quote
NYXH's Net Income Growth Rates NYXH's Ps Price to Sales ratio NYXH's Sales per Employee NYXH's Asset Turnover Ratio
NYXH's Net Margin NYXH's Pb Price to Book ratio NYXH's Financial Strength Ratios NYXH's Dividend Payout Ratio
Date modified: 2026-07-07T12:29:49+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Supernus Pharmaceuticals inc   1,102,687.12 $ 718.952  Million 652 
Stoke Therapeutics Inc   1,084,823.53 $ 184.420  Million 170 
Abbvie Inc   1,072,982.46 $ 61,160.000  Million 57,000 
Arvinas Inc   1,067,479.67 $ 262.600  Million 246 
Journey Medical Corp  1,066,517.24 $ 61.858  Million 58 
Arcutis Biotherapeutics Inc   1,062,350.28 $ 376.072  Million 354 
Madrigal Pharmaceuticals Inc   1,047,434.97 $ 958.403  Million 915 
Corcept Therapeutics Inc  1,043,023.29 $ 761.407  Million 730 
Biomarin Pharmaceutical Inc  1,000,078.55 $ 3,221.253  Million 3,221 
Coya Therapeutics Inc   993,219.13 $ 7.946  Million 8 
Assembly Biosciences Inc   990,452.05 $ 72.303  Million 73 
Travere Therapeutics Inc   987,380.28 $ 490.728  Million 497 
Hims and Hers Health Inc   961,252.25 $ 2,347.378  Million 2,442 
Sanara Medtech Inc   949,972.34 $ 102.597  Million 108 
Cue Biopharma Inc   947,103.45 $ 27.466  Million 29 
Lifevantage Corp  934,533.63 $ 208.401  Million 223 
Regeneron Pharmaceuticals Inc   930,752.76 $ 14,342.900  Million 15,410 
Ani Pharmaceuticals Inc  910,686.60 $ 883.366  Million 970 
Keenova Therapeutics Plc  906,562.50 $ 1,450.500  Million 1,600 
Scilex Holding Company  889,794.12 $ 30.253  Million 34 
Evolus Inc   889,541.92 $ 297.107  Million 334 
Day One Biopharmaceuticals Inc   888,662.92 $ 158.182  Million 178 
Xtant Medical Holdings Inc   882,602.65 $ 133.273  Million 151 
Nektar Therapeutics  876,698.41 $ 55.232  Million 63 
Pacira Biosciences inc   876,249.70 $ 726.411  Million 829 
Merck and Co Inc   866,813.33 $ 65,011.000  Million 75,000 
Carlisle Companies Incorporated  850,830.51 $ 5,019.900  Million 5,900 
Alphatec Holdings Inc   836,679.08 $ 763.888  Million 913 
Pfizer Inc  834,386.67 $ 62,579.000  Million 75,000 
Ardelyx inc   832,965.24 $ 407.320  Million 489 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.